Securities code: 688607 securities abbreviation: Careray Digital Medical Technology Co.Ltd(688607) Announcement No.: 2022-010 Careray Digital Medical Technology Co.Ltd(688607)
Announcement of resolutions of the sixth (Interim) meeting of the second board of supervisors
The board of supervisors and all supervisors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal liabilities for the authenticity, accuracy and integrity of its contents according to law.
1、 Meetings of the board of supervisors
Careray Digital Medical Technology Co.Ltd(688607) (hereinafter referred to as “the company”) the sixth (Interim) meeting of the second session of the board of supervisors was held at 11:00 a.m. on February 15, 2022 in the company’s conference room by on-site combined with communication voting. The meeting notice was sent to all supervisors by e-mail and telephone on February 13, 2022. The meeting was presided over by Mr. Guo Tao, chairman of the board of supervisors. Three supervisors should attend the meeting and three actually attended the meeting. The convening and convening procedures of this meeting comply with the provisions of relevant laws, administrative regulations, departmental rules, normative documents and the articles of association.
2、 Deliberation at the meeting of the board of supervisors
The attending supervisors carefully considered the following proposals and voted on the following matters:
1. The proposal on granting restricted shares to incentive objects for the first time was deliberated and adopted
After deliberation, the supervisors attending the meeting held that:
(1) The company is not prohibited from implementing the equity incentive plan as stipulated in the administrative measures for equity incentive of listed companies, and the company has the subject qualification to implement the equity incentive plan.
(2) The incentive objects granted with restricted shares have the qualifications specified in the company law and the securities law, meet the incentive object conditions specified in the Listing Rules of science and Innovation Board of Shanghai Stock Exchange, and meet the scope of incentive objects specified in the company’s 2022 restricted stock incentive plan (Draft). The subject qualification is legal and effective.
(3) The first grant date determined by the board of directors of the company complies with the provisions on the grant date in the administrative measures for equity incentive of listed companies and the company’s restricted stock incentive plan (Draft) in 2022.
To sum up, the company has achieved the grant conditions specified in the restricted stock incentive plan in 2022, and agreed to determine the first grant date as February 15, 2022, and grant a total of 3.2900 restricted shares to 99 incentive objects who meet the grant conditions at a grant price of 17.64 yuan / share.
Voting results: 3 in favor, 0 against, 0 abstention and 0 avoidance.
For details, please refer to the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) Announcement of Careray Digital Medical Technology Co.Ltd(688607) on granting restricted shares to incentive objects for the first time (Announcement No.: 2022-011) disclosed on.
2. Deliberated and passed the proposal on the proposed investment in the establishment of a wholly-owned subsidiary
Voting results: 3 in favor, 0 against, 0 abstention and 0 avoidance.
For details, please refer to the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) Announcement of Careray Digital Medical Technology Co.Ltd(688607) on foreign investment and establishment of wholly-owned subsidiaries (Announcement No.: 2022-012) disclosed on the.
It is hereby announced.
Careray Digital Medical Technology Co.Ltd(688607) board of supervisors February 16, 2022
